Alerts will be sent to your verified email
Verify Email
EMMESSA
|
Emmessar Biotech&Nut
|
Link Pharma Chem
|
Norris Medicines
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
13.7 % | 1.59 % | 47.03 % |
|
5yr average Equity Multiplier
|
1.24 | 1.99 | -2.46 |
|
5yr Average Asset Turnover Ratio
|
0.36 | 1.33 | 0.6 |
|
5yr Avg Net Profit Margin
|
71.53 % | -0.06 % | -30.66 % |
|
Price to Book
|
2.08 | 1.26 | 0.0 |
|
P/E
|
41.06 | 0.0 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
68.18 Days | 82.44 Days | 97.28 Days |
|
Inventory Days
|
62.21 Days | 64.96 Days | 165.43 Days |
|
Days Receivable
|
10.88 Days | 72.97 Days | 69.98 Days |
|
Days Payable
|
199.95 Days | 84.21 Days | 260.51 Days |
|
5yr Average Interest Coverage Ratio
|
815.2 | 2.35 | -1.37 |
|
5yr Avg ROCE
|
19.97 % | 5.35 % | -19.87 % |
|
5yr Avg Operating Profit Margin
|
-101.39 % | 3.76 % | -6.94 % |
|
5 yr average Debt to Equity
|
0.0 | 0.49 | -3.0 |
|
5yr CAGR Net Profit
|
0.0 | n/a | -15.97 % |
|
5yr Average Return on Assets
|
10.86 % | 0.6 % | -18.92 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
59.53 % | 51.49 % | 34.0 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
1.34 % | 0.0 | -0.04 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Emmessar Biotech&Nut
|
Link Pharma Chem
|
Norris Medicines
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|